Novavax shares are trading higher after vaccine makers said COVID shots for the JN.1 variant neutralize newer strains.
Portfolio Pulse from Benzinga Newsdesk
Novavax shares are trading higher after the company announced that its COVID-19 vaccine for the JN.1 variant is effective against newer strains.
June 05, 2024 | 4:09 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Novavax shares are trading higher after the company announced that its COVID-19 vaccine for the JN.1 variant is effective against newer strains.
The announcement that Novavax's COVID-19 vaccine for the JN.1 variant neutralizes newer strains is likely to boost investor confidence and drive the stock price higher in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100